home.aspx
 
.

Webinars

The Evolution of Cellulose in Tableting Technology
THE EVOLUTION OF CELLULOSE IN TABLETING TECHNOLOGY
September 25-25, 2019
In this webcast, learn about how the evolution from traditional powdered cellulose to microcrystalline cellulose to a new generation of co-processed high functionality excipients can benefit tableting processes including continuous manufacturing applications.

CRISPR 2019
CRISPR 2019
October 03-03, 2019
LabRoots invites you to the 2nd Annual CRISPR Virtual Event! This follows up event to a very popular first-year event will continue the conversation of the abilities of CRISPR-based editing, next-gen editing tools, precision in gene editing and using CRISPR for drug discovery. This event will bring ...

FDA & International Stability Requirements in the Drug Development Process including WHO, ASEAN and ICH Q1AR2
FDA & INTERNATIONAL STABILITY REQUIREMENTS IN THE DRUG DEVELOPMENT PROCESS INCLUDING WHO, ASEAN AND ICH Q1AR2
October 03-03, 2019
Stability is a Critical Quality Attribute, and stability program plays an important role in the Drug Development Process. It is necessary to determine the storage condition and expiry of pharmaceutical products. Several international guidelines have been issued for stability program and companies mu...

2019 Annual Pharmaceutical Stability Training Program
2019 ANNUAL PHARMACEUTICAL STABILITY TRAINING PROGRAM
October 03-03, 2019
As part of Good Manufacturing Practices (GMPs), stability program is required for all active pharmaceutical ingredients (API) and drug products to establish their label storage condition, retest date or expiration date. The objective of this 6-part program is to introduce the development and impleme...

Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations
MANUFACTURING AND MARKETING OTC DRUGS IN COMPLIANCE WITH FDA REGULATIONS
October 07-07, 2019
This webinar will provide attendees with the knowledge and skills needed to develop and produce an OTC drug product for marketing and sale in the U.S.

HVAC and GMP Environmental Control for Pharmaceutical Clean Rooms
HVAC AND GMP ENVIRONMENTAL CONTROL FOR PHARMACEUTICAL CLEAN ROOMS
October 08-08, 2019
This webinar first details and explains the various US and international regulatory requirements for various clean room classifications and provides a comprehensive overview of the mechanics of clean room HVAC.

Critical Success Factors for Pharma in Complex Customer Ecosystems
CRITICAL SUCCESS FACTORS FOR PHARMA IN COMPLEX CUSTOMER ECOSYSTEMS
October 08-08, 2019
To succeed, Pharma has an obligation to continually evolve its customer strategy. Critical Success Factors for Pharma in Complex Customer Ecosystems.

Elemental Impurities Compliance for the Pharmaceutical Industry
ELEMENTAL IMPURITIES COMPLIANCE FOR THE PHARMACEUTICAL INDUSTRY
October 08-08, 2019
The subject is of importance to the manufacturers of new drug products as they are required to comply with the new elemental impurities standards either through risk assessments or through testing as new regulatory submissions are made, and to manufacturers of existing products as they make decision...

The Anatomy of Local Anesthetic Injections
THE ANATOMY OF LOCAL ANESTHETIC INJECTIONS
October 09-09, 2019
This CE webinar will discuss both nerve and bone anatomy and how they can change the efficacy and ease of delivery of a local anesthetic. A review of the maxillary nerve, the mandibular nerve, the mandible and the maxilla will be discussed. Certain injection techniques and local anesthetic products ...

Effects of EU-Mercosur Trade Agreement (Pharma)
EFFECTS OF EU-MERCOSUR TRADE AGREEMENT (PHARMA)
October 10-10, 2019
This webinar will provide an overview of the Mercosur regulatory affairs system for pharmaceutical companies that want to benefit of the free-trade agreement signed between European Union and the South America trade bloc.

Cost & Management of Oncology Combination Regimens
COST & MANAGEMENT OF ONCOLOGY COMBINATION REGIMENS
October 30-30, 2019
Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator drugs (versus older, generic chemotherapies).

ENGINEERING FIRST PRINCIPLES: APPLICATIONS TO PHARMACEUTICAL MANUFACTURING
ENGINEERING FIRST PRINCIPLES: APPLICATIONS TO PHARMACEUTICAL MANUFACTURING
November 05-05, 2019
Within the pharmaceutical industry, creating a robust Operational Control Strategy (OCS) is a key step to accomplishing the goals of Quality by Design (QbD). Along the way to developing this robust Operational Control Strategy many problems will be encountered that need to be solved.

ENGINEERING FIRST PRINCIPLES: APPLICATIONS TO PHARMACEUTICAL MANUFACTURING
ENGINEERING FIRST PRINCIPLES: APPLICATIONS TO PHARMACEUTICAL MANUFACTURING
November 05-05, 2019
Within the pharmaceutical industry, creating a robust Operational Control Strategy (OCS) is a key step to accomplishing the goals of Quality by Design (QbD). Along the way to developing this robust Operational Control Strategy many problems will be encountered that need to be solved.

ICH Q12 - New approach to support innovation
ICH Q12 - NEW APPROACH TO SUPPORT INNOVATION
November 05-05, 2019
Progress has been made towards developing the new ICH Q12 Guideline on Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.

Influenza 2019
INFLUENZA 2019
November 06-06, 2019
This virtual, online conference will provide a single day packed with speaker sessions with industry experts, research poster presentations, and an exhibit hall with thought leaders from the field. Influenza 2019 is the perfect platform for leading scientists, researchers, practitioners, public heal...

SAP HANA Innovations Drive the Intelligent Enterprise
SAP HANA INNOVATIONS DRIVE THE INTELLIGENT ENTERPRISE
November 08-08, 2019
In this session, learn how SAP HANA fits into SAP’s Intelligent Enterprise strategy. Also hear about the latest innovations from SAP HANA including machine learning, data intelligence, multi-model processing, data security, multi-cloud, blockchain, non-volatile memory, rapid application develo...

Terumo Pharmaceutical Solutions and the Large Volume Injection Market
TERUMO PHARMACEUTICAL SOLUTIONS AND THE LARGE VOLUME INJECTION MARKET
November 12-12, 2019
Terumo Pharmaceutical Solutions is proud to present an evening dedicated to the current era of "Large Volume Injection". In today's LVI landscape, the delivery volume of subcutaneous injectable drugs is increasing and along with it the challenge of delivering drugs comfortably and with...

Clinical Diagnostics & Research 2019
CLINICAL DIAGNOSTICS & RESEARCH 2019
November 14-14, 2019
On November 14th thousands of will join in a discussion of the continuous progress made with advances in laboratory testing and patient care and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices...

The role of immune cells and immune checkpoints in multiple myeloma
THE ROLE OF IMMUNE CELLS AND IMMUNE CHECKPOINTS IN MULTIPLE MYELOMA
November 21-21, 2019
Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobulins in the bone marrow. Today there are many treatment modalities ongoing targeting the myeloma microenvironment, but especially immunotherapy seems to be a promising approac...

Utility of Generating Data: Drug Manufacture Perspective
UTILITY OF GENERATING DATA: DRUG MANUFACTURE PERSPECTIVE
January 21-21, 2020
Ken Wong is a Deputy Director of Process Technology Platform at Sanofi Pasteur. Serving as the Swiftwater site extractables and leachables (E&L) SME but also provide E&L supports to all global sites. His 19-year in biopharma professional career has ranged from R&D to development and comm...

UTILITY OF GENERATING <665> DATA: DRUG MANUFACTURE’S PERSPECTIVE: WILL USP PERMIT SUCH FORMAT?
UTILITY OF GENERATING <665> DATA: DRUG MANUFACTURE’S PERSPECTIVE: WILL USP PERMIT SUCH FORMAT?
January 21-21, 2020
Integrating Data in Drug Manufacturing, How Data and the Internet of Things Will Impact and Optimize Process. Integrating data from the drug development phase through drug manufacturing presents an additional set of challenges. As with drug development, the infrastructure needed to manage the data i...

2020 Annual Pharmaceutical Impurities Training Program
2020 ANNUAL PHARMACEUTICAL IMPURITIES TRAINING PROGRAM
February 05-05, 2020
As an important part of Good Manufacturing Practices (GMPs), monitoring impurities has been placed on the critical path of the development of pharmaceutical products. The objective of this live 4-part series is to thoroughly examine key best practices and regulations in this area. This live training...

HIGH-RESOLUTION CHARACTERIZATION OF STRUCTURE, INTERACTION, AND MISCIBILITY OF DRUG PRODUCTS
HIGH-RESOLUTION CHARACTERIZATION OF STRUCTURE, INTERACTION, AND MISCIBILITY OF DRUG PRODUCTS
February 11-11, 2020
The local interactions between a drug and its surrounding environment is critical in both small and large molecule formulations. For small molecules, the drug-polymer interaction is needed to ensure that the drug does not crystallize in an amorphous solid dispersion. For proteins, phase separation i...

2020 Annual Pharmaceutical Cleaning Validation Training Program
2020 ANNUAL PHARMACEUTICAL CLEANING VALIDATION TRAINING PROGRAM
February 25-25, 2020
Pharmaceutical manufacturers must validate their cleaning processes to ensure compliance with the latest regulatory requirements. Effective and consistent cleaning procedures must be in place and thoroughly validated to avoid cross-contamination in manufacturing and cleaning equipment. In recent yea...

Pharmaceutical Cleaning Validation
PHARMACEUTICAL CLEANING VALIDATION
May 21-21, 2020
For this live training webinar, regulatory issues related to validation maintenance will be discussed. Validation maintenance procedures covered include routine monitoring, preventive maintenance, change control, deviation management, retraining and revalidation. Under revalidation, both a repeat of...

SPOTLIGHT

Over the past few years, neuroscientists have been able to grow ever larger and more complex spheroid cultures and organoids that replicate the structure and functionality of brain tissue. While these...